...
首页> 外文期刊>Vaccine >Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico
【24h】

Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico

机译:抗猪带en虫囊虫病的合成肽疫苗:在墨西哥农村进行的一项受控田间试验中成功接种疫苗

获取原文
获取原文并翻译 | 示例
           

摘要

Taenia solium cysticercosis seriously affects human health when localised in the central nervous system (CNS) and causes great economic loss in pig husbandry in rural areas of endemic countries. Increasing the resistance to the parasite in the obligatory host pig may help in curbing transmission. Three synthetic peptides based on protein sequences of the murine parasite Taenia crassiceps, which had previously been shown to induce protection in mice against homologous challenge, were tested as a vaccine against T solium cysticercosis in pigs. Vaccinated and unvaccinated piglets (240 in all) were distributed in pairs among the peasants' households of two rural villages in Mexico in which 14% of the native pigs were cysticercotic. Ten to twelve months later, the effect of vaccination was evaluated at necropsy. Vaccination decreased the total number of T solium cysticerci (98.7%) and reduced the prevalence (52.6%). The natural challenge conditions used in this field trial strengthen the likelihood of successful transmission control to both pig and human through a large-scale pig vaccination program. We believe this is a major contribution in anticysticercosis vaccine development as these rather simple yet protective peptides are potentially more cost-effective to produce and less variable in results than antigens that are more complex.
机译:虫囊尾rc虫病局限于中枢神经系统(CNS)时,会严重影响人类健康,并在流行国家农村地区的养猪业中造成巨大的经济损失。强制性寄主猪对寄生虫的抵抗力增强可能有助于遏制传播。测试了三种基于鼠寄生虫Taenia crassiceps蛋白质序列的合成肽,这些肽以前被证明可以诱导小鼠抵抗同源攻击,并且可以作为猪T囊尾rc病的疫苗。在墨西哥两个乡村的农民家庭中,成对分配了接种过的和未接种过的仔猪(总共240头),成对的猪中有14%是囊虫病的。十到十二个月后,尸检时评估疫苗接种的效果。疫苗接种减少了囊状丁酸梭菌的总数(98.7%),减少了患病率(52.6%)。通过大规模的猪疫苗接种计划,该田间试验中使用的自然挑战条件增加了成功控制猪和人的传播的可能性。我们认为,这是抗囊尾rc病疫苗开发的主要贡献,因为与较为复杂的抗原相比,这些相当简单而又具有保护性的肽生产起来可能更具成本效益,并且结果可变性较小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号